LYZL2

Chr 10

lysozyme like 2

Also known as: LYZD2

The LYZL2 protein is a lysozyme-like enzyme that functions as a bacteriolytic factor in host defense against bacterial infections. Mutations in LYZL2 cause disease, though the specific clinical phenotypes are not detailed in the available information. The gene shows minimal constraint against loss-of-function variants based on population genetics data.

Summary from RefSeq
Research Assistant →
0
Active trials
0
Pubs (1 yr)
10
P/LP submissions
0%
P/LP missense
1.79
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryLYZL2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
10 unique Pathogenic / Likely Pathogenic· 35 VUS of 54 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.79LOEUF
pLI 0.000
Z-score -0.36
OE 1.13 (0.691.79)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.77Z-score
OE missense 1.20 (1.051.38)
139 obs / 115.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.13 (0.691.79)
00.351.4
Missense OE1.20 (1.051.38)
00.61.4
Synonymous OE1.10
01.21.6
LoF obs/exp: 10 / 8.8Missense obs/exp: 139 / 115.7Syn Z: -0.57
DN
0.6358th %ile
GOF
0.6737th %ile
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

54 submitted variants in ClinVar

Classification Summary

Pathogenic9
Likely Pathogenic1
VUS35
Likely Benign5
Benign1
9
Pathogenic
1
Likely Pathogenic
35
VUS
5
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
9
0
9
Likely Pathogenic
0
0
1
0
1
VUS
0
23
12
0
35
Likely Benign
0
2
2
1
5
Benign
0
0
1
0
1
Total02525151

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

LYZL2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 2 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found